Top-News

Tvardi Therapeutics Aktie News

Aktie
WKN:  A414VY ISIN:  US1407553072 US-Symbol:  TVRD Branche:  Biotechnologie Land:  USA
3,64 €
+0,035 €
+0,97%
22:13:32 Uhr
Depot/Watchlist
Marktkapitalisierung *
5,27 Mio. €
Streubesitz
69,71%
KGV
-0,39
Index-Zuordnung
-

Tvardi Therapeutics News

04.12.25 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PR Newswire
30.11.25 - PR Newswire
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PR Newswire
21.11.25 - PR Newswire
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PR Newswire
14.11.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi PR Newswire
03.11.25 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PR Newswire
28.10.25 - PR Newswire
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PR Newswire
23.10.25 - PR Newswire
Faruqi & Faruqi Reminds Tvardi Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 - TVRD
Faruqi & Faruqi Reminds Tvardi Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 - TVRD PR Newswire
15.10.25 - PR Newswire
TVRD SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
TVRD SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PR Newswire
21.02.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders PR Newswire
07.01.25 - PR Newswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders PR Newswire
23.12.24 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders PR Newswire
22.12.24 - Boersia.de
Cara Therapeutics Aktie: Ein starker Antrieb für Investitionen!
Die Cara Therapeutics Aktie zeigt eine bemerkenswerte Aufwärtsbewegung zum Jahresende. Am 21. Dezember 2024 erreichte der Aktienkurs 0,4226 USD, was einem Tagesplus ...
21.12.24 - Boersia.de
Cara Therapeutics Aktie: Kleiner Schritt, große Wirkung!
Die Cara Therapeutics Aktie zeigt eine bemerkenswerte Aufwärtsbewegung zum Ende des Jahres 2024. Am 20. Dezember verzeichnete das Biopharma-​Unternehmen einen ...
18.12.24 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cara Therapeutics, Inc. - CARA
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cara Therapeutics, Inc. - CARA PR Newswire
18.12.24 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »